Fanhua Inc. — FY2021 Form 20-F Summary
Issuer and period: The supplied filing is Fanhua Inc.’s annual report for the fiscal year ended December 31, 2021, filed April 29, 2022—not a 2021 Q4 report. The request metadata names AIFU Inc., but the filing itself identifies Fanhua Inc. (Nasdaq: FANH). Financial statements are prepared under U.S. GAAP and reported primarily in RMB.
Business context
Fanhua is a China-focused insurance intermediary, earning commissions and fees from insurance distribution and claims-adjusting services. Life insurance is its largest business. The Cayman Islands holding company operates mainly through PRC subsidiaries and, for online insurance distribution, a variable-interest entity (VIE) structure.
Key financial results
| Metric | FY2020 | FY2021 | Change |
|---|---|---|---|
| Net revenue | RMB3,268.1m | RMB3,271.1m (US$513.3m) | +0.1% |
| Operating income | RMB302.2m | RMB301.9m | -0.1% |
| Net income | RMB276.2m | RMB259.9m | -5.9% |
| Net income attributable to shareholders | RMB268.3m | RMB251.0m (US$39.4m) | -6.4% |
| Operating cash flow | RMB402.3m | RMB126.2m | Down substantially |
| Cash and cash equivalents | RMB245.4m | RMB564.6m | — |
| Short-term investments | RMB1,307.9m | RMB870.7m | — |
| Total assets / liabilities | RMB3,081.0m / RMB1,126.3m | RMB3,242.1m / RMB1,281.8m | — |
Revenue mix: Agency revenue was RMB2,811.9m, including life insurance revenue of RMB2,679.7m and P&C revenue of RMB132.2m. Claims-adjusting revenue was RMB459.2m. Life insurance represented 81.9% of total revenue; claims adjusting, 14.0%.
Margins and liquidity: Operating costs were 64.7% of revenue, versus 67.7% in 2020; operating margin was approximately 9.2% in both years. Net margin declined to approximately 7.9% from 8.4%. Current assets of RMB2,266.1m compared with current liabilities of RMB908.7m imply a current ratio of about 2.5. Cash flow from operations fell despite essentially flat revenue, with contract assets increasing RMB257.2m among the reported working-capital movements.
Debt and cash uses: The company reported no short- or long-term bank borrowings at year-end. Operating lease liabilities totaled RMB215.3m. FY2021 investing cash flow was RMB450.4m, largely reflecting maturities and purchases of short-term investments; financing cash outflow was RMB260.3m, including RMB242.5m of dividends.
Material changes and unusual items
- Net revenue was nearly flat, while agency revenue declined 0.8% and claims-adjusting revenue grew 6.0%. Life insurance gross written premium rose 12.5% to RMB11.3bn, but product mix and COVID-related effects weighed on recognized life revenue.
- FY2021 life-insurance revenue included RMB258.7m of estimated renewal commissions recognized under a new estimation approach. Management reduced the constraint on estimated renewal commissions to 86%; the estimate was identified as a critical audit matter and depends on future policy renewals and assumptions.
- General and administrative expense increased 18.1% to RMB547.6m, attributed principally to strategic initiative spending and the normalization of employee social-benefit contributions after temporary 2020 relief. Headquarters operating loss widened to RMB108.4m.
- The company recorded a RMB29.3m other-than-temporary impairment on its CNFinance investment. The overall share of income and impairment of affiliates was a net loss of RMB20.6m.
- Fanhua re-established a VIE structure for online insurance operations in December 2021: its direct ownership of Xinbao Investment fell from 100% to 49%, with 51% nominally held by an employee, alongside contractual control and economic-benefit arrangements. The VIE contributed 0.5% of consolidated revenue and represented 2.2% of assets at year-end.
Outlook, risks and contingencies
Management expects current cash and anticipated operating cash flow to cover working capital and capital expenditure needs for at least 12 months. It plans continued investment in a more professional sales force, digital capabilities and an open platform, but provided no quantified earnings or revenue guidance. The filing notes that spending and capital commitments may rise over the next two to three years.
- China regulatory and legal uncertainty is significant, including online-insurance rules, data and cybersecurity oversight, foreign investment restrictions and the enforceability of VIE contracts. The filing says the CAC had not notified the company that it was a critical information infrastructure operator; applicability of evolving review rules remained uncertain.
- The auditor, Deloitte’s mainland China firm, was on the PCAOB list of firms that could not be fully inspected. The company had not been identified as an HFCA Act issuer as of the filing date, but disclosed potential U.S. trading prohibition or delisting risk if inspection requirements were not met.
- Revenue depends on insurance-company relationships: Sinatay, Aeon and Huaxia contributed 15.0%, 14.5% and 10.7% of FY2021 revenue, respectively. Agent retention, commission rates, competition, COVID-19 disruptions and changing product availability are additional operating risks.
- The company reported RMB73.2m of unrecognized tax benefits/uncertain tax liabilities, largely relating to disposal gains and transfer-pricing arrangements. It reported RMB491,000 in aggregate regulatory fines in 2021 and no material pending litigation.
- A consortium led by founder and CEO Yinan Hu submitted a preliminary, non-binding going-private proposal on December 16, 2021 at US$9.80 per ADS. No definitive offer had been made by the report date; completion was not assured.
- The board declared a fourth-quarter 2021 dividend of US$0.15 per ADS in March 2022. Future dividends remain discretionary and subject to cash availability, PRC distribution restrictions and other conditions.
Audit and controls: Deloitte issued an unqualified opinion on the FY2021 financial statements and on internal control over financial reporting. The filing also flags the PCAOB inspection limitation noted above. Management reported effective disclosure controls and internal controls as of December 31, 2021.
Most important facts for investors to verify
- Confirm issuer and period: this is Fanhua Inc.’s FY2021 annual filing, not an AIFU Inc. filing or a standalone Q4 report.
- Assess the quality and cash conversion of the RMB258.7m estimated renewal commissions, including later renewal experience and contract-asset collection.
- Reconcile the sharp decline in operating cash flow with earnings, contract assets, commission accruals and other working-capital changes.
- Review VIE restructuring documents, nominee-shareholder arrangements, online-insurance licensing status and the practical ability to enforce contractual control.
- Monitor PCAOB inspection and HFCA Act developments, China regulatory approvals and the status of the proposed going-private transaction.
- Check the share-count disclosures: the cover page reports 1,074,291,784 ordinary shares, while the audited balance sheet reports 1,073,891,784 issued and outstanding at year-end; the filing also reports dilutive options.